Cargando…

Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021

Evidence on COVID-19 vaccine efficacy/effectiveness (VE) in preventing asymptomatic SARS-CoV-2 infections is needed to guide public health recommendations for vaccinated people. We report interim results of a living systematic review. We identified a total of 30 studies that investigated VE against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harder, Thomas, Koch, Judith, Vygen-Bonnet, Sabine, Külper-Schiek, Wiebe, Pilic, Antonia, Reda, Sarah, Scholz, Stefan, Wichmann, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284046/ https://www.ncbi.nlm.nih.gov/pubmed/34269175 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.28.2100563

Ejemplares similares

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
por: Harder, Thomas, et al.
Publicado: (2021)

Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
por: Harder, Thomas, et al.
Publicado: (2021)

Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
por: Külper-Schiek, Wiebe, et al.
Publicado: (2022)

Outbreak of imported diphtheria with Corynebacterium diphtheriae among migrants arriving in Germany, 2022
por: Badenschier, Franziska, et al.
Publicado: (2022)

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
por: Treskova-Schwarzbach, Marina, et al.
Publicado: (2021)

Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel
por: Pilic, Antonia, et al.
Publicado: (2023)

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019)

Hepatitis A outbreak associated with consumption of dates, England and Wales, January 2021 to April 2021
por: Garcia Vilaplana, Tatiana, et al.
Publicado: (2021)

A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
por: Waize, M, et al.
Publicado: (2022)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform
por: Mosina, Liudmila, et al.
Publicado: (2021)

Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
por: Sullivan, Sheena G, et al.
Publicado: (2017)

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021
por: Fernández-Prada, María, et al.
Publicado: (2021)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017
por: Vygen-Bonnet, Sabine, et al.
Publicado: (2017)

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
por: Di Domenico, Laura, et al.
Publicado: (2021)

Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
por: Fonager, Jannik, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021
por: Calba, Clémentine, et al.
Publicado: (2021)

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
por: Singanayagam, Anika, et al.
Publicado: (2020)

Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021
por: Sacco, Chiara, et al.
Publicado: (2021)

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021
por: Marrone, Gaetano, et al.
Publicado: (2022)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens
por: Zimmermann, Ruth, et al.
Publicado: (2020)

Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021
por: Hobson, Gemma, et al.
Publicado: (2021)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018–21 January 2019: early findings
Publicado: (2019)

Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
por: Indenbaum, Victoria, et al.
Publicado: (2021)

Ongoing mumps outbreak in Israel, January to August 2017
por: Indenbaum, Viki, et al.
Publicado: (2017)

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
por: Kahn, Fredrik, et al.
Publicado: (2022)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2022)

Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18
por: Chiu, Susan S, et al.
Publicado: (2018)

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
por: Buil, Jochem B, et al.
Publicado: (2021)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022
por: Marsh, Kimberly, et al.
Publicado: (2022)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
por: Rondy, Marc, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_76s9kaskr51bpq41lnuqnltqjn